Papillon Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$100K
- Investors
-
4
Papillon Therapeutics General Information
Description
Operator of a biotechnology company intended to advance new therapies tailored to address lysosomal and mitochondrial dysfunctions that underlie life-threatening inherited conditions. The company specializes in developing gene-modified hematopoietic stem and progenitor cell (HSPC) therapies, leveraging the natural capacity of these unique human cells to perform the multi-systemic repair of damaged tissues, enabling patients with neurologic disease, including Friedreich's ataxia, Danon disease, and Alzheimer's disease to get quality treatment.
Contact Information
Website
www.papillon-tx.comCorporate Office
- 3210 Merryfield Row
- JLABS
- San Diego, CA 92121
- United States
Corporate Office
- 3210 Merryfield Row
- JLABS
- San Diego, CA 92121
- United States
Papillon Therapeutics Timeline
Papillon Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 11-Sep-2024 | $100K | Completed | Clinical Trials - Phase 2 | ||
| 3. Angel (individual) | 15-Apr-2024 | Completed | Clinical Trials - Phase 2 | |||
| 2. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 1. University Spin-Out | 01-Jan-2021 | Completed | Clinical Trials - Phase 1 |
Papillon Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Papillon Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Papillon Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| TL Foundation | Not-For-Profit Venture Capital | Minority | ||
| NuFund Venture Group | Angel Group | Minority | ||
| University of California, San Diego | University | |||
| CONNECT (San Diego) | Accelerator/Incubator | Minority |
Papillon Therapeutics FAQs
-
When was Papillon Therapeutics founded?
Papillon Therapeutics was founded in 2021.
-
Where is Papillon Therapeutics headquartered?
Papillon Therapeutics is headquartered in San Diego, CA.
-
What is the size of Papillon Therapeutics?
Papillon Therapeutics has 5 total employees.
-
What industry is Papillon Therapeutics in?
Papillon Therapeutics’s primary industry is Drug Discovery.
-
Is Papillon Therapeutics a private or public company?
Papillon Therapeutics is a Private company.
-
What is Papillon Therapeutics’s current revenue?
The current revenue for Papillon Therapeutics is .
-
How much funding has Papillon Therapeutics raised over time?
Papillon Therapeutics has raised $100K.
-
Who are Papillon Therapeutics’s investors?
TL Foundation, NuFund Venture Group, University of California, San Diego, and CONNECT (San Diego) have invested in Papillon Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
